Effects of obesity on nutritional status and biochemical parameters in maintenance hemodialysis patients with chronic renal failure

2008 ◽  
Vol 18 (3) ◽  
pp. S9
2005 ◽  
Vol 15 (2) ◽  
pp. 225-230 ◽  
Author(s):  
Vincenzo Savica ◽  
Domenico Santoro ◽  
Giampiero Mazzaglia ◽  
Franco Ciolino ◽  
Paolo Monardo ◽  
...  

1989 ◽  
Vol 35 (2) ◽  
pp. 704-711 ◽  
Author(s):  
Larry A. Slomowitz ◽  
Francisco J. Monteon ◽  
Mary Grosvenor ◽  
Steward A. Laidlaw ◽  
Joel D. Koppel

2016 ◽  
Vol 31 (suppl_1) ◽  
pp. i558-i559
Author(s):  
Zeynep Bal ◽  
Ruya Ozelsancak ◽  
Gultekin Genctoy ◽  
Oznur Kal ◽  
Emre Tutal ◽  
...  

1981 ◽  
Vol 4 (3) ◽  
pp. 130-134 ◽  
Author(s):  
A. Zarate ◽  
M. Gelfand ◽  
A. Novello ◽  
J. Knepshield ◽  
H.G. Preuss

Propranolol is widely employed in hemodialysis patients for the control of renin-dependent hypertension. Infrequent reports have linked hypoglycemia and propranolol, especially in complex situations such as malnutrition, anesthesia, and excessive insulin use. Three patients on maintenance hemodialysis taking propranolol developed severe hypoglycemia resulting in cardiac arrest. The life-threatening hypoglycemia occurred without apparent precipitating cause and unaccompanied by the classical signs and symptoms of hypoglycemia. These three cases suggest that propranolol in a setting of chronic renal failure and dialysis may bring about severe hypoglycemia, a complication previously unsuspected.


Sign in / Sign up

Export Citation Format

Share Document